Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gender decrease » teer decrease (Expand Search)
Showing 1,081 - 1,100 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((gender decrease) OR (greater decrease)) ))', query time: 0.58s Refine Results
  1. 1081
    Uganda: enrolment, time to IVA, mortality, admissions and readmissions.

    Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1082
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1083
    Bluetooth beacons with colour coded lanyards.

    Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1084
    Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site.

    Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1085
    Lymphocyte proliferation assay following combination therapy with NDV.

    Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  6. 1086
    Tumor volume measurements.

    Tumor volume measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  7. 1087
    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold change (2<sup>-ΔΔCt</sup>). miRNAs with a fold change greater than 1.3 in the vehicle group and at the 0.75–1.3 range (orange striped area) in the Bz and Bz + PTX therapy groups were considered to have a restored expression. They were selected for further analysis on IPA software. (A) The expression of miRNAs was altered in the infected group and an expression was restored after Bz therapy. (B) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (C) Diseases and disorders pathway analysis. (D) The expression of miRNAs was altered in the infected group and restored upon Bz + PTX therapy. (E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals

    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold chang... by Glaucia Vilar-Pereira (686134)

    Published 2025
    Save to List
    Saved in:
  8. 1088
    IL-10 levels in tumor lysates post-treatment.

    IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  9. 1089
    Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10<sup>7</sup> CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated withA. TYL (3 times, q7D), B. LMC (3 times, q7D), C. sham (3 times, q7D), D. OTC (3 times, q4D), E. OTC (1 time) and F. sham (3 times, q4D. Red-dotted line represents calculated inoculation dose (CFU/bee) administered on day 1. *, represents significant differences from D3 bacterial load, with P < 0.05.

    Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10<sup>7</sup> CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated... by Midhun Sebastian Jose (19336846)

    Published 2025
    Save to List
    Saved in:
  10. 1090
    Hypnotic and sedative (N05C) prescribing changes from 2014 to 2022.

    Hypnotic and sedative (N05C) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1091
    Drugs used in addictive disorders (N07B) prescribing changes from 2014 to 2022.

    Drugs used in addictive disorders (N07B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1092
    Anxiolytic (N05B) prescribing changes from 2014 to 2022.

    Anxiolytic (N05B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1093
    Antidepressant (N06A) prescribing changes from 2014 to 2022.

    Antidepressant (N06A) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1094
    Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022.

    Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1095
    Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022.

    Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1096
    Regional differences in percentage changes of N07BA drug prescribing rates during the pandemic.

    Regional differences in percentage changes of N07BA drug prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1097
    Regional differences in percentage changes of N05B prescribing rates during the pandemic.

    Regional differences in percentage changes of N05B prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1098
    Regional differences in percentage changes of N05C prescribing rates during the pandemic.

    Regional differences in percentage changes of N05C prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1099
    Regional differences in percentage changes of N06A prescribing rates during the pandemic.

    Regional differences in percentage changes of N06A prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1100
    Regional differences in percentage changes of N07BC drug prescribing rates during the pandemic.

    Regional differences in percentage changes of N07BC drug prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: